Business Context and Reporting Period
Company: Armstrong World Industries, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: September 9, 2013
Purpose: The filing clarifies the description of the Company's common stock and material provisions of its Amended and Restated Articles of Incorporation. This description is intended to be incorporated by reference into future registration statements on Form S-3 and Form S-8.
Key Financial Metrics
This filing is a corporate governance and capital structure disclosure. It does not contain financial performance data. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
There are no material changes to financial operations or results reported in this document. The filing serves to update the legal description of the Company's capital stock and governance rules for regulatory compliance purposes.
Capital Structure, Governance, and Risks
Authorized Capital Stock
- Common Shares: 200,000,000 authorized shares, par value $0.01 per share. Listed on NYSE under symbol "AWI".
- Preferred Shares: 15,000,000 authorized shares, without par value. The Board may issue these without shareholder action, potentially diluting common shareholders or restricting dividends.
Asbestos Trust Provisions
Until the Armstrong World Industries, Inc. Asbestos Personal Injury Settlement Trust (the "Asbestos Trust") ceases to beneficially own at least 20% of outstanding common shares, the following restrictions apply:
- Transfer Restrictions: The Trust cannot transfer voting shares to a purchaser who would own more than 35% of voting shares or more than the Trust's current holdings, subject to specific exceptions (e.g., public sales, pro-rata transactions).
- Related Party Transactions: Transactions between the Company and the Trust require approval by a majority of "Disinterested Directors."
- Corporate Actions: The Company cannot authorize new share classes, issue non-conventional preferred shares, or adopt shareholder rights plans without the Trust's written consent.
- Board Composition: The Board must ensure that a majority of directors are independent.
- Amendments: Affirmative vote of the Asbestos Trust is required to amend these specific provisions.
Anti-Takeover Provisions
- Authorized but Unissued Shares: Available for future issuance without shareholder approval, potentially discouraging takeover attempts.
- Pennsylvania Law: The Company is subject to Pennsylvania Business Corporation Law (PBCL) anti-takeover statutes, though Articles explicitly exempt certain subchapters.
- Shareholder Meetings: Special meetings can only be called by shareholders holding at least 20% of voting shares.
- Voting: No cumulative voting for director elections.
- Amendments: Certain Articles and Bylaw provisions require an 80% shareholder vote to amend while a shareholder owns at least 20% of common shares.
Investor Verification Checklist
- Verify the current beneficial ownership percentage of the Asbestos Trust to determine if the 20% threshold restrictions remain active.
- Review the "Stockholder and Registration Rights Agreement" (Exhibit 10.1) for detailed terms governing the relationship with the Asbestos Trust.
- Confirm the specific rights attached to any preferred shares if the Board elects to issue them in the future.
- Assess the impact of the 80% supermajority voting requirement on potential future amendments to governance provisions.